Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Biosimilars: informing patients and physicians

Bertrand Coiffier • 22 Jun 2017
EHA 2017

Bertrand Coiffier, MD from the Centre Hospitalier Lyon-Sud, Pierre-Bénite, France highlights the importance of educating patients on biosimilars so they can appreciate the benefits associated with their use. Furthermore, it is also necessary for healthcare practitioners to understand the advantages of biosimilars. This interview was recorded at the annual meeting of the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

More from Bertrand Coiffier

2:40
Understanding biosimilars
Bertrand Coiffier • 22 Jun 2017
3:27
Why we need novel strategies for diffuse large B-cell lymphoma
Bertrand Coiffier • 22 Jun 2017
1:28
Biosimilars in oncology: EHA 2017 session on rituximab
Bertrand Coiffier • 22 Jun 2017
1:30
ASH 2014: Phase III Lyma trial of rituximab maintenance after ASCT in mantle cell lymphoma
Bertrand Coiffier • 5 Dec 2014
The content of VJHemOnc is intended for healthcare professionals